Pharmaceuticals & Healthcare Products (88)
-
Algeria Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Africa / Algeria Pharmaceuticals & Healthcare Industry Report
BMI calculates the value of Algeria’s pharmaceutical consumption to have been DZD169.55bn (US$2.36bn) in 2009. The market is characterised by a relatively low per-capita spend of US$68 and a large gen... Read MoreWeb Price: $975 -
Argentina Pharmaceuticals & Healthcare Report
Pub date: 10 Aug 2010 Latin America / Argentina Pharmaceuticals & Healthcare Industry Report
The value of Argentina’s pharmaceutical market is calculated to have reached ARS12.64bn (US$3.37bn) in 2009. Thro ugh to 2014, we forecast a compound annual growth rate (CAGR) of 14.36% and 9.78% in l... Read MoreWeb Price: $975 -
Australia Pharmaceuticals & Healthcare Report
Pub date: 10 Aug 2010 Asia / Australia Pharmaceuticals & Healthcare Industry Report
Measured in local currency terms, Australia’s AUD10.07bn (US$7.74bn) pharmaceutical market is forecast to post a compound annual growth rate (CAGR) of 3.28% over the next 10 years (down from a rate of... Read MoreWeb Price: $975 -
Bahrain Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Middle East / Bahrain Pharmaceuticals & Healthcare Industry Report
A population of just 738,000 limits the overall pharmaceutical market in Bahrain. In 2009 Bahrain’s pharmaceutical market was worth just BHD43mn (US$112mn) but this is expected to reach BHD54mn (US$14... Read MoreWeb Price: $975 -
Bangladesh Pharmaceuticals & Healthcare Report
Pub date: 2 Jun 2010 Asia / Bangladesh Pharmaceuticals & Healthcare Industry Report
Out of the 16 key markets surveyed in BMI’s Pharmaceuticals & Healthcare Business Environment Ratings, Bangladesh moves up two places to occupy 14th position in the table. This improvement sees it now... Read MoreWeb Price: $975 -
Belarus Pharmaceuticals & Healthcare Report
Pub date: 15 Jul 2010 Europe / Belarus Pharmaceuticals & Healthcare Industry Report
Belarus came through the global economic crisis far more smoothly than neighbours such as Russia and Ukraine, a measure of the country’s disengagement from the broader European and global economies. I... Read MoreWeb Price: $975 -
Belgium Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Europe / Belgium Pharmaceuticals & Healthcare Industry Report
Having received a somewhat lower compound score in Q310, Belgium is now placed joint fifth in the Western Europe Pharmaceuticals & Healthcare Business Environment Ratings (BER) matrix, on a par with t... Read MoreWeb Price: $975 -
Brazil Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Latin America / Brazil Pharmaceuticals & Healthcare Industry Report
Since the last quarter, we have revised our forecast slightly downward for Brazil as a result of concerns over the persisting fiscal slippage and the increasing role of politics in the economy in the... Read MoreWeb Price: $975 -
Bulgaria Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Europe / Bulgaria Pharmaceuticals & Healthcare Industry Report
BMI considers Bulgaria to be among the less attract ive pharmaceutical markets in Emerging Europe, a view largely enforced by poor market dynamics and prolonged economic difficulties. In BMI ’s Pharma... Read MoreWeb Price: $975 -
Cambodia Pharmaceuticals & Healthcare Report
Pub date: 23 Jul 2010 Asia / Cambodia Pharmaceuticals & Healthcare Industry Report
Cambodia’s pharmaceutical market was calculated to be worth KHR711bn (US$172mn) in 2009. BMI forecasts drug consumption to increase at a rate of 11.6% over the next five years to reach a value of KH... Read MoreWeb Price: $975 -
Canada Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 North America / Canada Pharmaceuticals & Healthcare Industry Report
In BMI ’s updated Americas Business Environment Ratings (BER) for Q310, Canada remains in second place in the expanded regional matrix, a position to which it rose in the previous quarter, having move... Read MoreWeb Price: $975 -
Central America Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Latin America / El Salvador Pharmaceuticals & Healthcare Industry Report
Despite the region’s worsening macroeconomic performance, the business environment for multinational pharmaceutical companies in Central America has improved slightly since Q310, due to marginal impro... Read MoreWeb Price: $975 -
Chile Pharmaceuticals & Healthcare Report
Pub date: 7 Jul 2010 Latin America / Chile Pharmaceuticals & Healthcare Industry Report
In BMI’s Q310 Business Environment Ratings for the 17 markets of the Americas, Chile receives a composite pharmaceutical rating of 37.6, falling to 11th place in the Americas matrix of countries. We ... Read MoreWeb Price: $975 -
China Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Asia / China Pharmaceuticals & Healthcare Industry Report
In the Asia Pacific Pharmaceuticals & Healthcare BERs for Q310, China has maintained fourth position of the 16 markets covered in Asia Pacific, with an above average pharmaceutical rating of 61.3. Chi... Read MoreWeb Price: $975 -
Colombia Pharmaceuticals & Healthcare Report
Pub date: 17 Jun 2010 Latin America / Colombia Pharmaceuticals & Healthcare Industry Report
Colombia occupies sixth position (up from seventh previously). BMI calculates pharmaceutical sales in Colombia reached a value of COP4,819bn (US$2.24bn) in 2009, and we expect the market to post a ste... Read MoreWeb Price: $975 -
Croatia Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Europe / Croatia Pharmaceuticals & Healthcare Industry Report
Croatia’s pharmaceutical market, valued at HRK5.74bn (US$1.10bn) in 2009, is calculated to have fallen by 4.95% year-on-year (y-o-y) in local currency terms, mostly due to pressures from strict pricin... Read MoreWeb Price: $975 -
Czech Republic Pharmaceuticals & Healthcare Report
Pub date: 15 Jul 2010 Europe / Czech Republic Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings for Emerging Europe in Q310, the Czech Republic retained its pole position, which it climbed to the previous quarter surpassing Greece. The country’s scores in t... Read MoreWeb Price: $975 -
Egypt Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Africa / Egypt Pharmaceuticals & Healthcare Industry Report
Egypt’s total pharmaceutical spending, which reached EGP13.75bn (US$2.48bn) in 2009, is expected to continue growing steadily over BMI’s five- and ten-year forecast periods. We expect the market value... Read MoreWeb Price: $975 -
Estonia Pharmaceuticals & Healthcare Report
Pub date: 19 Aug 2010 Europe / Estonia Pharmaceuticals & Healthcare Industry Report
Estonia’s attractiveness to pharmaceutical companies ha s improved in recent months, as can be seen in BMI ’s regional Pharmaceutical & Healthcare Business Environm ent Ratings (BER) for Q410. Estonia... Read MoreWeb Price: $975 -
France Pharmaceuticals & Healthcare Report
Pub date: 13 Jul 2010 Europe / France Pharmaceuticals & Healthcare Industry Report
France scores well in our Q310 Pharmaceuticals and Healthcare Business Environment Ratings – it is ranked 10 th globally (out of the 82 markets in BMI ’s coverage universe) and fourth in our Western E... Read MoreWeb Price: $975 -
Germany Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Europe / Germany Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings (BER) for Q410, Germany retained its position as the most attractive pharmaceutical market in Western Europe, out of the ten countries surveyed. The ratings cri... Read MoreWeb Price: $975 -
Ghana Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Africa / Ghana Pharmaceuticals & Healthcare Industry Report
In the BMI ’s Business Environment Ratings (BER) for the 19 markets in the Middle East and Africa (MEA) region, Ghana receives a composite pharmaceutical rating of 39.1, ranking the country 15 th , th... Read MoreWeb Price: $975 -
Greece Pharmaceuticals & Healthcare Report
Pub date: 30 Jun 2010 Europe / Greece Pharmaceuticals & Healthcare Industry Report
country is translating into clear operating difficulties for the industry, both in Greece and potentially elsewhere. While Greece maintains a strong score within our Business Environment Ratings for t... Read MoreWeb Price: $975 -
Hong Kong Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Asia / Hong Kong Pharmaceuticals & Healthcare Industry Report
Environment Ratings (BERs) for Q310, which now includes Cambodia to rank 16 key markets. While Hong Kong poses few risks to investment, the overall score is negatively impacted by the small overall ma... Read MoreWeb Price: $975 -
Hungary Pharmaceuticals & Healthcare Report
Pub date: 18 Aug 2010 Europe / Hungary Pharmaceuticals & Healthcare Industry Report
In BMI’s Emerging Europe Business Environment Ratings (BER) for Q410, Hungary continued to improve and is now ranked fourth (out of the 20 markets surveyed), up from sixth and eighth in the previous t... Read MoreWeb Price: $975 -
India Pharmaceuticals & Healthcare Report
Pub date: 7 Jul 2010 Asia / India Pharmaceuticals & Healthcare Industry Report
It is BMI's view that India's attractiveness to drugmakers is improving dramatically. According to primary market research firm AIOCD Pharmasofttech AWACS, sales of pharmaceuticals expanded by 23.0% i... Read MoreWeb Price: $975 -
Indonesia Pharmaceuticals & Healthcare Report
Pub date: 25 May 2010 Asia / Indonesia Pharmaceuticals & Healthcare Industry Report
In the BMI Business Environment Rating matrix for Q310, we see Indonesia continue to occupy 12th position of the 16 regional markets surveyed in the Asia Pacific region. The country’s pharmaceutical r... Read MoreWeb Price: $975 -
Iran Pharmaceuticals & Healthcare Report
Pub date: 18 Aug 2010 Middle East / Iran Pharmaceuticals & Healthcare Industry Report
Iran’s pharmaceutical market was worth IRN22,765bn (US$2.31bn) in 2009. BMI forecasts a compound annual growth rate (CAGR) of 13% year-on-year (y-o-y) to 2014, when the drug market should be worth ar... Read MoreWeb Price: $975 -
Iraq Pharmaceuticals & Healthcare Report
Pub date: 7 Jul 2010 Middle East / Iraq Pharmaceuticals & Healthcare Industry Report
The growth of Iraq’s pharmaceutical market in the long-term is inextricably linked to an oil-driven economic expansion, which in turn depends on the government’s ability to represent and appease the c... Read MoreWeb Price: $975 -
Israel Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Middle East / Israel Pharmaceuticals & Healthcare Industry Report
BMI expects the total pharmaceutical market in Israel to increase in value from ILS6.14bn (US$1.56bn) in 2009 to ILS6.52bn (US$1.84bn) by 2014, at a compound annual growth rate (CAGR) of 3.2% in US do... Read MoreWeb Price: $975 -
Italy Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Europe / Italy Pharmaceuticals & Healthcare Industry Report
In BMI 's Q410 Pharmaceuticals & Healthcare Business Envi ronment Ratings (BERs), the Western Europe region scored a total of 64.5 out of 100. The attractiven ess of the region to pharmaceutical firms... Read MoreWeb Price: $975 -
Japan Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Asia / Japan Pharmaceuticals & Healthcare Industry Report
Japan is no longer the most attractive pharmace utical market in Asia Pacific, according to BMI 's Q310 Pharmaceuticals & Healthcare Business Environment Ratings (BERs) for the region. Prospects for m... Read MoreWeb Price: $975 -
Jordan Pharmaceuticals & Healthcare Report
Pub date: 27 Aug 2010 Middle East / Jordan Pharmaceuticals & Healthcare Industry Report
While we continue to see Jordan as one of the moderately attractive markets in the Middle East and North Africa (MENA) region – with the country ranked 12 th of the 19 regional markets by BMI ’s Busin... Read MoreWeb Price: $975 -
Kazakhstan Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Europe / Kazakhstan Pharmaceuticals & Healthcare Industry Report
BMI retains its robust five-year growth forecast for the Kazakhstan pharmaceutical market, with the US dollar value of the market rebounding on the back of a resurgent local currency in 2010. Our for... Read MoreWeb Price: $975 -
Kenya Pharmaceuticals & Healthcare Report
Pub date: 6 Aug 2010 Africa / Kenya Pharmaceuticals & Healthcare Industry Report
It is BMI’s view that the Kenyan government's budget, released on June 10 2010, is its most ambitious to date. With a focus on long-term economic development, the government plans to spend KES996.82bn... Read MoreWeb Price: $975 -
Kuwait Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Middle East / Kuwait Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings (BER) for Q310, Kuwait is ranked fifth of the 19 markets now surveyed in the Middle East and Africa (MEA) region. Having been fourth previously, Kuwait has been o... Read MoreWeb Price: $975 -
Latvia Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Europe / Latvia Pharmaceuticals & Healthcare Industry Report
Latvia’s pharmaceutical market is currently overshadowed by sharp cuts as part of the government’s austerity package, which is aimed at securing European Union and International Monetary Fund financin... Read MoreWeb Price: $975 -
Lebanon Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Middle East / Lebanon Pharmaceuticals & Healthcare Industry Report
Lebanon’s pharmaceutical market was valued at LBP778bn (US$518mn) in 2009. BMI forecasts that drug expenditure should reach LBP1,061bn (US$709mn) in 2014, representing a CAGR of 6.4% over the five-y... Read MoreWeb Price: $975 -
Lithuania Pharmaceuticals & Healthcare Report
Pub date: 7 Jul 2010 Europe / Lithuania Pharmaceuticals & Healthcare Industry Report
Our new Q310 Business Environment Ratings (BER) matrix for Emerging Europe places Lithuania in 15 th position of the 20 markets surveyed. Lithuania’s pharmaceutical market score is the second-lowest i... Read MoreWeb Price: $975 -
Malaysia Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Asia / Malaysia Pharmaceuticals & Healthcare Industry Report
Leading Malayisan drugmaker Pharmaniaga expects the outlook for the Malaysian pharmaceutical industry to improve in 2010. This view is in accordance with BMI's Pharmaceutical Expenditure Forecast Mode... Read MoreWeb Price: $975 -
Mexico Pharmaceuticals & Healthcare Report
Pub date: 6 Aug 2010 Latin America / Mexico Pharmaceuticals & Healthcare Industry Report
Mexico is considered the fifth most attractive market in the Americas region (out of the 17 countries surveyed). Globally, Mexico ranks 24th, out of the 83 markets surveyed in the Q410 Business Enviro... Read MoreWeb Price: $975 -
Moldova Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Europe / Moldova Pharmaceuticals & Healthcare Industry Report
Moldova’s pharmaceutical market was valued at US$208mn in 2009, and BMI calculates that the market will post a compound annual growth rate (CAGR) of 4.95% between 2009 and 2014 in US dollar terms, inc... Read MoreWeb Price: $975 -
Morocco Pharmaceuticals & Healthcare Report
Pub date: 7 Jul 2010 Africa / Morocco Pharmaceuticals & Healthcare Industry Report
BMI’s Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underline some of our key views about how the sector is performing in emerging markets. In particular, we ... Read MoreWeb Price: $975 -
Netherlands Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Europe / Netherlands Pharmaceuticals & Healthcare Industry Report
BMI calculates that drug sales in the Netherlands reach ed EUR6.00bn (US$8.45bn) at consumer prices in 2009. Thro ugh to 2014, we expect the market to stagnate, posting a local currency compound annua... Read MoreWeb Price: $975 -
Nigeria Pharmaceuticals & Healthcare Report
Pub date: 12 Aug 2010 Africa / Nigeria Pharmaceuticals & Healthcare Industry Report
Pharmaceutical firms have long regarded Nigeria with interest, chiefly because of its massive middleclass class population and rising GDP, although we caution that much of that GDP depends on oil reve... Read MoreWeb Price: $975 -
Oman Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Middle East / Oman Pharmaceuticals & Healthcare Industry Report
BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets. In particular we hi... Read MoreWeb Price: $975 -
Pakistan Pharmaceuticals & Healthcare Report
Pub date: 20 Aug 2010 Asia / Pakistan Pharmaceuticals & Healthcare Industry Report
According to BMI ’s Pharmaceutical Expenditure Forecast Mode l, combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan will increase from PKR136.61bn (US$1.67bn) in 2009... Read MoreWeb Price: $975 -
Peru Pharmaceuticals & Healthcare Report
Pub date: 1 Jul 2010 Latin America / Peru Pharmaceuticals & Healthcare Industry Report
In BMI ’s Pharmaceuticals & Healthcare Business Environment Ratings (BER) for Q310, we have significantly expanded the number of countries surveyed in the Americas region. Peru now places eighth of th... Read MoreWeb Price: $975 -
Philippines Pharmaceuticals & Healthcare Report
Pub date: 12 Aug 2010 Asia / Philippines Pharmaceuticals & Healthcare Industry Report
The Philippines remains ranked 11th in our Asia Pacific Business Environment Ratings (BER) table for Q410. Globally, the country places 49th of the 83 markets now surveyed in our pharmaceutical univer... Read MoreWeb Price: $975 -
Poland Pharmaceuticals & Healthcare Report
Pub date: 10 Aug 2010 Europe / Poland Pharmaceuticals & Healthcare Industry Report
Propped up by its large population, Poland has surfaced as one of the most important global emerging markets, with its value in 2009 calculated at PLN30.25bn (US$10.26bn) at retail prices. Over a fiv... Read MoreWeb Price: $975 -
Portugal Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Europe / Portugal Pharmaceuticals & Healthcare Industry Report
Portugal’s pharmaceutical sales reached a value of EUR3.62bn (US$5.10bn) in 2009. It is BMI's view that the slowdown in drug market growth in Portugal in recent years will continue in 2010, with drug ... Read MoreWeb Price: $975 -
Puerto Rico Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Caribbean / Puerto Rico Pharmaceuticals & Healthcare Industry Report
Puerto Rico’s pharmaceutical market was worth US$2.71bn in 2009 and BMI forecasts this figure to grow at compound annual growth rate (CAGR) of 3.5% through to 2014, reaching a value of US$3.22bn. We p... Read MoreWeb Price: $975 -
Qatar Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Middle East / Qatar Pharmaceuticals & Healthcare Industry Report
The total pharmaceutical market in Qatar will rise from a value of US$233mn in 2009 to US$419mn by 2014, at a CAGR of 12.45%. The proportion of GDP accounted for by drug spending will be 0.26% by this... Read MoreWeb Price: $975 -
Romania Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Europe / Romania Pharmaceuticals & Healthcare Industry Report
Romania’s pharmaceutical market is among the most dynamic in the EU, yet drugmakers face significant regulatory hurdles in accessing the market. BMI’s Business Environment Ratings for Emerging Europe ... Read MoreWeb Price: $975 -
Russia Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Europe / Russia Pharmaceuticals & Healthcare Industry Report
In line with Russia’s economic recovery this year, BMI expects the pharmaceutical sector to post 22.4% US dollar growth in 2010 – a figure enhanced by the appreciation of the rouble in relation to the... Read MoreWeb Price: $975 -
Saudi Arabia Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Middle East / Saudi Arabia Pharmaceuticals & Healthcare Industry Report
In 2009, Saudi Arabia’s pharmaceutical market wa s calculated to be worth US$2.77bn at consumer prices. Through to 2014, BMI forecasts that this figure will grow at a compound annual growth rate (CAGR... Read MoreWeb Price: $975 -
Serbia Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Europe / Serbia Pharmaceuticals & Healthcare Industry Report
Serbia’s pharmaceutical sector is being hampered by difficult economic and political conditions but will grow year-on-year (y-o-y) from 2010. The country’s recent emergence from a recession combined w... Read MoreWeb Price: $975 -
Singapore Pharmaceuticals & Healthcare Report
Pub date: 16 Jun 2010 Asia / Singapore Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings (BER) table for Q310, Singapore is ranked fifth of the 16 markets assessed in the Asia Pacific region., up from the previous quarter and improving further upon it... Read MoreWeb Price: $975 -
Slovakia Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Europe / Slovakia Pharmaceuticals & Healthcare Industry Report
In the BMI emerging Europe pharmaceutical Business Environment Ratings for Q310, Slovakia scored a virtually unchanged 56.7. However, this score now puts Slovakia in seventh position out of the 20 reg... Read MoreWeb Price: $975 -
Slovenia Pharmaceuticals & Healthcare Report
Pub date: 27 Aug 2010 Europe / Slovenia Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings (BERs) table for Q410, Slovenia is ranked ninth of the 20v markets assessed in CEE, up by one place in relation to the previous quarter. Overall, Slovenia’s attra... Read MoreWeb Price: $975 -
South Africa Pharmaceuticals & Healthcare Report
Pub date: 15 Jul 2010 Africa / South Africa Pharmaceuticals & Healthcare Industry Report
BMI’s Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets. In particular we ... Read MoreWeb Price: $975 -
South Korea Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Asia / South Korea Pharmaceuticals & Healthcare Industry Report
BMI would describe South Korea as a transitional pharmaceutical market. Characteristic of an emergingmarket, combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to p... Read MoreWeb Price: $975 -
Spain Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Europe / Spain Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings for Q310, Spain continued to fall down the matrix. It is now rated eighth out of the 10 countries surveyed, having alr eady dropped one place to fifth in the prev... Read MoreWeb Price: $975 -
Sri Lanka Pharmaceuticals and Healthcare Report
Pub date: 23 Jul 2010 Asia / Sri Lanka Pharmaceuticals & Healthcare Industry Report
According to BMI's drug expenditure forecast model, sales of pharmaceuticals in Sri Lanka are expected to increase from LKR38.97bn (U$339mn) in 2009 to LKR43.88bn (US$388mn) in 2010. Due to the stre... Read MoreWeb Price: $975 -
Sweden Pharmaceuticals & Healthcare Report
Pub date: 18 Aug 2010 Europe / Sweden Pharmaceuticals & Healthcare Industry Report
In BMI 's Q410 Pharmaceuticals & Healthcare Business Environment Ratings, the Western Europe region scored a total of 64.5 out of a 100. The attractiveness of the region to pharmaceutical firms stems ... Read MoreWeb Price: $975 -
Switzerland Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Europe / Switzerland Pharmaceuticals & Healthcare Industry Report
BMI calculates that drug sales in Switzerland reached CHF6.07bn (US$5.57bn) in 2009. It is expected that in 2010, drug sales will decline to CHF5.95bn (US$5.61bn), equating to negative growth of 1.98%... Read MoreWeb Price: $975 -
Taiwan Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Asia / Taiwan Pharmaceuticals & Healthcare Industry Report
Globally, Taiwan’s TWD123.4bn (US$3.8 1bn) pharmaceutical market is viewed as the 27 th most attractive, out of the 83 markets surveyed within our ever-expanding pharmaceutical universe. However, alth... Read MoreWeb Price: $975 -
Thailand Pharmaceuticals & Healthcare Report
Pub date: 12 Aug 2010 Asia / Thailand Pharmaceuticals & Healthcare Industry Report
BMI believes the recent unrest in Thailand will not have an immediate impact on pharmaceutical sales or the revenue earning opportunities of drugmakers because the demand for healthcare is relatively ... Read MoreWeb Price: $975 -
Turkey Pharmaceuticals & Healthcare Report
Pub date: 26 Aug 2010 Europe / Turkey Pharmaceuticals & Healthcare Industry Report
BMI’s outlook for pharmaceutical companies operating in the Emerging Europe region has improved further over the past quarter, as shown by our updated Pharmaceuticals and Healthcare Business Environme... Read MoreWeb Price: $975 -
Ukraine Pharmaceuticals & Healthcare Report
Pub date: 17 Jun 2010 Europe / Ukraine Pharmaceuticals & Healthcare Industry Report
Ukraine’s economy suffered its worst one-off decline since the bad old days of the 1990s, with GDP contracting by 15.3%, according to initial estimates. Battered by price controls and a dizzying numbe... Read MoreWeb Price: $975 -
United Arab Emirates Pharmaceuticals & Healthcare Report
Pub date: 22 Jun 2010 Middle East / United Arab Emirates Pharmaceuticals & Healthcare Industry Report
In 2009, the UAE pharmaceutical market reached a value of AED5.08bn (US$1.38bn). In 2010, we forecast the drug market will be worth AED5.84bn (U S$1.59bn), experiencing a growth of 14.9%. By 2014, we ... Read MoreWeb Price: $975 -
United Kingdom Pharmaceuticals & Healthcare Report
Pub date: 3 Aug 2010 Europe / United Kingdom Pharmaceuticals & Healthcare Industry Report
In BMI’s Business Environment Ratings for Q310, the UK has maintained its fifth place out of the ten Western European markets surveyed. The ratings criteria serve to reinforce our estimation of t... Read MoreWeb Price: $975 -
United States Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 North America / United States Pharmaceuticals & Healthcare Industry Report
Despite the potentially profit-limiting changes of reform, the US remains the highest potential pharmaceutical market globally. Reinforcing this view, the US ranks first in BMI ’s Business Environment... Read MoreWeb Price: $975 -
Uzbekistan Pharmaceuticals & Healthcare Report
Pub date: 18 Aug 2010 Europe / Uzbekistan Pharmaceuticals & Healthcare Industry Report
BMI’s growth projection for Uzbekistan’s pharmaceutical market remains largely unchanged this quarter, with its five-year com pound annual growth rate (CAGR) forecast at 10.37% in US dollar terms betw... Read MoreWeb Price: $975 -
Venezuela Pharmaceuticals & Healthcare Report
Pub date: 15 Jul 2010 Latin America / Venezuela Pharmaceuticals & Healthcare Industry Report
In our updated Q310 Pharmaceutical Business Environment Ratings (BER) for the Americas, Venezuela remains third from the bottom, above Nicaragua an d Honduras, with a pharmaceutical rating of 34.0. Gl... Read MoreWeb Price: $975 -
Vietnam Pharmaceuticals & Healthcare Report
Pub date: 29 Jun 2010 Asia / Vietnam Pharmaceuticals & Healthcare Industry Report
Vietnam is still regarded as one of the least attractive regional pharmaceutical markets for foreign involvement, due to a combination of economic and regulatory drawbacks. Nevertheless, over our fore... Read MoreWeb Price: $975 -
Zimbabwe Pharmaceuticals & Healthcare Report
Pub date: 1 Sep 2010 Africa / Zimbabwe Pharmaceuticals & Healthcare Industry Report
Zimbabwe remains firmly at the bottom of BMI’s Business Environment Ratings for Q310, which looks at 19 key regional markets, now including Ghana and Iraq. Although an improvement on last quarter, th... Read MoreWeb Price: $975 -
America’s Medical Device Markets
Pub date: 21 Oct 2008 North America / United States Pharmaceuticals & Healthcare Special Report
5-year forecasts, regulatory information and company developments for 10 key medical device markets in the Americas.... Read MoreWeb Price: $675 -
Biosimilars: Obama Unfolds New Opportunities
Pub date: 6 Apr 2009 Global Pharmaceuticals & Healthcare Special Report
BMI explores challenges and opportunities in researching, developing and commercialising biosimilars, with an emphasis on regulatory issues... Read MoreWeb Price: $675 -
Burden Of Disease Database
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMI’s Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read MoreWeb Price: $675 -
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read MoreWeb Price: $490 -
Frontier Pharmaceutical Markets: Underserved And Underappreciated
Pub date: 18 Jun 2009 Global Pharmaceuticals & Healthcare Special Report
Frontier pharmaceutical markets are high-risk but offer substantial returns. BMI looks at five cases studies from around the world.... Read MoreWeb Price: $675 -
Global Economic Downturn: Implications For The Pharmaceutical Industry
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read MoreWeb Price: $675 -
Healthcare Reform In The Emerging Markets – The New Role Of Health Insurance
Pub date: 12 May 2009 Global Pharmaceuticals & Healthcare Special Report
The World Health Organization (WHO) has been heavily involved in monitoring and advising developing nations on the logistics of reforming the healthcare sector. We note that drugmakers, medical ... Read MoreWeb Price: $675 -
Neglected Tropical Diseases: New Opportunities
Pub date: 24 Sep 2009 Global Pharmaceuticals & Healthcare Special Report
Diseases can be classified as neglected when the cost of innovation, clinical trials and marketing are considered to be far more than the potential revenues. With no cost benefit, firms have not... Read MoreWeb Price: $675 -
Pharmaceutical Pricing: Dynamics In A Global Market
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read MoreWeb Price: $490 -
Pharmaceutical Regulatory Convergence: The Case For A Global Agency
Pub date: 12 Jun 2009 Global Pharmaceuticals & Healthcare Special Report
Negotiating global regulatory variations is a major challenge for multinational drugmakers. Will harmonisation ease the path to commercial success?... Read MoreWeb Price: $675 -
The Patent Cliff: Strategies And Tactics For Survival
Pub date: 16 Sep 2009 Global Pharmaceuticals & Healthcare Special Report
The patent cliff is arguably the greatest challenge facing multinational drugmakers. In this special report, BMI outlines the strategies and tactics needed for survival.... Read MoreWeb Price: $675